Hikma Launches US Vascepa Rival As Amarin Appeal Denied

Initially Offering Limited Quantities As Firm Scales Up Production

 
• By David Wallace
Launch
Hikma has pressed ahead with its launch of a generic version of Vascepa • Source: Shutterstock

More from Products

More from Generics Bulletin